|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
General Assembly Invitation
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Agenda Items
|
||||||||||||||||||||||
|
1 - Opening and formation of the Meeting Chairmanship
|
||||||||||||||||||||||
|
2 - Reading and discussion of the Board of Directors' Annual Report for the 2024 activity period
|
||||||||||||||||||||||
|
3 - Reading and discussing the summary of the Independent Auditor's Report for the activity period of 2024
|
||||||||||||||||||||||
|
4 - Reading, discussion and approval of the Financial Statements for the activity period of 2024
|
||||||||||||||||||||||
|
5 - Separate release of the members of the Board of Directors for the transactions, acts and affairs of the Company for the year 2024
|
||||||||||||||||||||||
|
6 - Discussing and resolving on the proposal of the Board of Directors regarding the profit/loss for 2024, prepared within the framework of the Company's profit distribution policy
|
||||||||||||||||||||||
|
7 - Determination of the remuneration of the members of the Board of Directors and their rights such as attendance fees, bonuses and premiums
|
||||||||||||||||||||||
|
8 - Informing the shareholders about the payments made to the members of the Board of Directors and senior executives in accordance with the Corporate Governance Principles
|
||||||||||||||||||||||
|
9 - Submission of the independent audit firm determined by the Board of Directors for the year 2025 for the approval of the General Assembly
|
||||||||||||||||||||||
|
10 - In accordance with the regulations of the Capital Markets Board, within the scope of the Company's Donation and Aid Policy, providing information about the donations and aids made by the Company in 2024 and determining the upper limit for donations to be made in 2025
|
||||||||||||||||||||||
|
11 - Pursuant to the Capital Markets Board regulations, informing the shareholders about the guarantees, pledges, mortgages and sureties given in favour of third parties within the accounting period of 2024 and the income or benefits derived therefrom
|
||||||||||||||||||||||
|
12 - Authorising the shareholders who control the management, members of the Board of Directors, senior executives and their spouses and relatives by blood and marriage up to the second degree within the framework of Articles 395 and 396 of the Turkish Commercial Code No. 6102 and informing the shareholders about the transactions carried out in this context in 2024 in line with the Capital Markets Board Corporate Governance Communiqué
|
||||||||||||||||||||||
|
13 - Wishes and closure
|
||||||||||||||||||||||
|
Corporate Actions Involved In Agenda
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
General Assembly Results
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Decisions Regarding Corporate Actions
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
General Assembly Registry
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Additional Explanations
|
||||||||||||||||||||||
|
The Ordinary General Assembly Meeting of our company held on 29.04.2025 was registered by the Balıkesir Trade Registry Office on 05.05.2025. This statement has been translated into English for informative purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure, the Turkish version shall prevail. |